Anticancer therapeutics : from drug discovery to clinical applications /
An integrated presentation of the basic science and clinical applications of anticancer agents Aimed at both undergraduate and postgraduate readers, this unique text provides readers with a fully-integrated presentation of all aspects of the science of anticancer drugs, including their chemistry, ph...
Clasificación: | Libro Electrónico |
---|---|
Autores principales: | , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Hoboken, NJ :
Wiley,
2017.
|
Edición: | First edition. |
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Intro
- Title Page
- Copyright Page
- Contents
- Preface
- Section 1 Introduction
- Chapter 1.1 The Global Burden of Cancer
- References
- Chapter 1.2 Cancer Staging and Classification
- 1.2.1 Benign Tumour (or neoplasm)
- 1.2.2 Malignant Tumour (or cancer)
- 1.2.3 Tumour Nomenclature and Classification
- 1.2.4 Cellular Differentiation and Tumour Grade
- 1.2.5 Tumour Invasion and Metastasis
- 1.2.6 Clinical Staging of Cancer
- References
- Chapter 1.3 Cellular and Molecular Basis of Cancer
- 1.3.1 Oncogenes
- 1.3.2 Tumour Suppressor Genes
- 1.3.3 Role of Epigenetics and Gene Promoter Regulation in Tumourigenesis
- 1.3.4 Multistage Tumourigenesis
- 1.3.5 Oncogene Addiction
- 1.3.6 Hallmarks of Cancer
- 1.3.7 Principles of Cancer Treatment
- References
- Section 2 The Anticancer Agents
- Chapter 2.1 Agents Which Act Directly on DNA
- 2.1.1 Nitrogen Mustards and Nitrosoureas
- References
- 2.1.2 Temozolomide
- References
- 2.1.3 Platinum-containing agents
- References
- 2.1.4 Gemcitabine
- References
- 2.1.5 Camptothecin and Its Analogues
- References
- 2.1.6 Podophyllotoxins
- References
- 2.1.7 Anthracyclines [1]
- References
- 2.1.8 Epigenetic Targeting Agents [1]
- References
- Chapter 2.2 Antimetabolites
- 2.2.1 Cytarabine
- References
- 2.2.2 Methotrexate
- References
- 2.2.3 5-Fluorouracil
- References
- 2.2.4 6-Mercaptopurine
- References
- Chapter 2.3 Antimicrotubule agents
- 2.3.1 Taxanes
- References
- 2.3.2 Vinca Alkaloids
- References
- Chapter 2.4 Anti-hormonal agents
- 2.4.1 Bicalutamide
- References
- 2.4.2 Tamoxifen
- References
- 2.4.3 Anastrozole [1]
- References
- Chapter 2.5 Kinase Inhibitors
- 2.5.1 Discovery
- 2.5.2 Synthesis
- 2.5.3 Mode of Action
- 2.5.4 Mechanism of Resistance [32]
- 2.5.5 Adverse Drug Reactions
- References
- Section 3 The Cancers.
- Chapter 3.1 Breast Cancer
- 3.1.1 Epidemiology
- 3.1.2 Presentation
- 3.1.3 Diagnosis
- 3.1.4 Staging
- 3.1.5 Treatments
- References
- Chapter 3.2 Colorectal cancer
- 3.2.1 Epidemiology
- 3.2.2 Presentation
- 3.2.3 Diagnosis
- 3.2.4 Staging
- 3.2.5 Treatments
- References
- Chapter 3.3 Leukaemia
- 3.3.1 Epidemiology
- 3.3.2 Presentation
- 3.3.3 Diagnosis
- 3.3.4 Staging
- 3.3.5 Treatments
- References
- Chapter 3.4 Lung cancer
- 3.4.1 Epidemiology
- 3.4.2 Presentation
- 3.4.3 Diagnosis
- 3.4.4 Staging
- 3.4.5 Treatments
- References
- Chapter 3.5 Oesophageal Cancer
- 3.5.1 Epidemiology
- 3.5.2 Presentation
- 3.5.3 Diagnosis
- 3.5.4 Staging
- 3.5.5 Treatments
- References
- Chapter 3.6 Ovarian cancer
- Key points
- 3.6.1 Epidemiology
- 3.6.2 Presentation
- 3.6.3 Diagnosis
- 3.6.4 Staging
- 3.6.5 Treatments
- References
- Chapter 3.7 Pancreatic Cancer
- 3.7.1 Epidemiology
- 3.7.2 Presentation
- 3.7.3 Diagnosis
- 3.7.4 Staging
- 3.7.5 Treatments
- References
- Chapter 3.8 Prostate Cancer
- 3.8.1 Epidemiology
- 3.8.2 Presentation
- 3.8.3 Diagnosis
- 3.8.4 Staging
- 3.8.5 Treatments
- References
- Chapter 3.9 Skin Cancers
- 3.9.1 Epidemiology
- 3.9.2 Presentation
- 3.9.3 Diagnosis
- 3.9.4 Staging
- 3.9.5 Treatments
- References
- Chapter 3.10 Testicular cancer
- 3.10.1 Epidemiology
- 3.10.2 Presentation
- 3.10.3 Diagnosis
- 3.10.4 Staging
- 3.10.5 Treatments
- References
- Index
- EULA.